{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:25:33Z","timestamp":1768829133275,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.brachy.2022.11.014","type":"journal-article","created":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T23:13:27Z","timestamp":1674429207000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5346-7486","authenticated-orcid":false,"given":"Constanze","family":"Heinze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Damm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Othmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-8871","authenticated-orcid":false,"given":"Maximilian","family":"Thormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-3943","authenticated-orcid":false,"given":"Alexey","family":"Surov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-5284","authenticated-orcid":false,"given":"Peter","family":"Hass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-5410","authenticated-orcid":false,"given":"Max","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Powerski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7140-6775","authenticated-orcid":false,"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazan","family":"Omari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2022.11.014_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2022.11.014_bib0002","doi-asserted-by":"crossref","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0003","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.11.014_bib0006","first-page":"348","article-title":"Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions","volume":"32","author":"Bolondi","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.brachy.2022.11.014_bib0007","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jgh.12452","article-title":"Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis","volume":"29","author":"Ha","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","article-title":"Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT","volume":"61","author":"Yin","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0009","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4254\/wjh.v8.i14.607","article-title":"Liver resection for intermediate hepatocellular carcinoma","volume":"8","author":"Yi","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.11236","article-title":"Mortality after liver surgery in Germany","volume":"106","author":"Filmann","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.brachy.2022.11.014_bib0011","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2009.07.1700","article-title":"Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival","volume":"78","author":"Mohnike","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.11.014_bib0012","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00330-011-2352-7","article-title":"Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours","volume":"22","author":"Collettini","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00066-014-0781-3","article-title":"CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma","volume":"191","author":"Collettini","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000218350","article-title":"Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma","volume":"27","author":"Mohnike","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.brachy.2022.11.014_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00270-018-2127-5","article-title":"Radioablation by image-guided (HDR) brachytherapy and transarterial chemoembolization in hepatocellular carcinoma: a randomized phase II trial","volume":"42","author":"Mohnike","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0016","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00261-018-1744-4","article-title":"White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI","volume":"43","author":"Elsayes","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.brachy.2022.11.014_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2015.01.018","article-title":"Accuracy of applicator tip reconstruction in MRI-guided interstitial 192Ir-high-dose-rate brachytherapy of liver tumors","volume":"115","author":"Wybranski","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0018","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2003.09.024","article-title":"CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique","volume":"58","author":"Ricke","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.11.014_bib0019","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ijrobp.2006.02.052","article-title":"In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy","volume":"65","author":"Streitparth","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.11.014_bib0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00066-016-0957-0","article-title":"Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy: complications and risk factors","volume":"192","author":"Mohnike","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0021","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5114\/jcb.2018.80626","article-title":"Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements","volume":"10","author":"Damm","year":"2018","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2022.11.014_bib0022","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"issue":"Suppl 3","key":"10.1016\/j.brachy.2022.11.014_bib0023","first-page":"1203","article-title":"Pathology of early hepatocellular carcinoma: progression from early to advanced","volume":"45","author":"Kojiro","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.brachy.2022.11.014_bib0024","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncr.20798","article-title":"Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma","volume":"103","author":"Sasaki","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2022.11.014_bib0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00268-003-7308-x","article-title":"Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin","volume":"28","author":"Shi","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.brachy.2022.11.014_bib0026","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00534-007-1312-8","article-title":"Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification","volume":"15","author":"Ueno","year":"2008","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.brachy.2022.11.014_bib0027","first-page":"59","article-title":"The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma","volume":"11","author":"Cho","year":"2005","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jgh.12441","article-title":"Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma","volume":"29","author":"Fang","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0029","first-page":"801","article-title":"[Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]","volume":"86","author":"L\u00fc","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.brachy.2022.11.014_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11605-019-04503-7","article-title":"Factors affecting local and intra hepatic distant recurrence after surgery for Hcc: an alternative perspective on microvascular invasion and satellitosis \u2013 a Western European Multicentre Study","volume":"25","author":"Famularo","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.brachy.2022.11.014_bib0031","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer \u22642 cm: results from two Western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.brachy.2022.11.014_bib0032","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00535-011-0492-9","article-title":"Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma","volume":"47","author":"Kinugasa","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0033","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","article-title":"Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma","volume":"22","author":"Sacco","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0034","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jvir.2012.12.013","article-title":"Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?","volume":"24","author":"Golfieri","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.brachy.2022.11.014_bib0036","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1148\/rg.2017160122","article-title":"Chemoembolization of hepatocellular carcinoma with extrahepatic collateral blood supply: anatomic and technical considerations","volume":"37","author":"Moustafa","year":"2017","journal-title":"Radiographics"},{"key":"10.1016\/j.brachy.2022.11.014_bib0037","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00270-009-9697-1","article-title":"The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization","volume":"33","author":"Miyayama","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0038","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","article-title":"Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design","volume":"56","author":"Burrel","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0039","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jamcollsurg.2008.01.020","article-title":"Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma","volume":"207","author":"Lam","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.brachy.2022.11.014_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204412","article-title":"Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis","volume":"13","author":"Ioannou","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.brachy.2022.11.014_bib0041","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2288-11-38","article-title":"Progression of liver cirrhosis to HCC: an application of hidden Markov model","volume":"11","author":"Bartolomeo","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0042","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.brachy.2022.11.014_bib0043","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/cancers13020192","article-title":"Stereotactic radiotherapy for hepatocellular carcinoma, radiosensitization strategies and radiation-immunotherapy combination","volume":"13","author":"P\u00e9rez-Romasanta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2022.11.014_bib0044","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.3748\/wjg.v11.i44.7040","article-title":"Cell survival curve for primary hepatic carcinoma cells and relationship between SF(2) of hepatic carcinoma cells and radiosensitivity","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.brachy.2022.11.014_bib0045","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/cancers12040872","article-title":"Vinorelbine augments radiotherapy in hepatocellular carcinoma","volume":"12","author":"Yeoh","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2022.11.014_bib0046","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.brachy.2022.11.014_bib0047","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.brachy.2022.11.014_bib0048","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1748-717X-5-24","article-title":"Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases","volume":"5","author":"Seidensticker","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.11.014_bib0049","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s00270-016-1423-1","article-title":"Haemorrhagic complications and symptomatic venous thromboembolism in interventional tumour ablations: the impact of peri-interventional thrombosis prophylaxis","volume":"39","author":"Mohnike","year":"2016","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122003932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122003932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:38Z","timestamp":1761531518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472122003932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1538472122003932"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2022.11.014","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2022.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}